KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Other financing activities (2016 - 2021)

Historic Other financing activities for Resmed (RMD) over the last 12 years, with Q4 2021 value amounting to $16.1 million.

  • Resmed's Other financing activities rose 475.6% to $16.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $162.9 million, marking a year-over-year increase of 1022.0%. This contributed to the annual value of $63.9 million for FY2021, which is 1195.62% up from last year.
  • As of Q4 2021, Resmed's Other financing activities stood at $16.1 million, which was up 475.6% from $17.3 million recorded in Q3 2021.
  • In the past 5 years, Resmed's Other financing activities ranged from a high of $113.9 million in Q2 2021 and a low of -$618000.0 during Q1 2018
  • Its 4-year average for Other financing activities is $32.4 million, with a median of $15.5 million in 2020.
  • As far as peak fluctuations go, Resmed's Other financing activities surged by 217572.82% in 2019, and later surged by 475.6% in 2021.
  • Quarter analysis of 4 years shows Resmed's Other financing activities stood at $12.5 million in 2018, then rose by 12.09% to $14.1 million in 2019, then grew by 9.34% to $15.4 million in 2020, then increased by 4.76% to $16.1 million in 2021.
  • Its Other financing activities stands at $16.1 million for Q4 2021, versus $17.3 million for Q3 2021 and $113.9 million for Q2 2021.